{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:58:26Z","timestamp":1793120306129,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Gastroenterology, Royal Berkshire Hospital"},{"name":"the Health Innovation Partnership between the University of Reading"},{"name":"Royal Berkshire Foundation Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>The gut microbiota in active ulcerative colitis (UC) differs from that of healthy individuals. Human milk oligosaccharides (HMOs) are prebiotics found in human breastmilk which promote infant health, but are lesser studied in adults. The objective of this study was to assess the impact of the HMO 2\u2032-fucosyllactose (2\u2032-FL) on symptoms, inflammation, gut microbiota, and systemic metabolism in mild-to-moderate UC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this randomized, double-blind, placebo-controlled crossover clinical trial, 38 patients with mild-to-moderate UC were randomized to receive 28\u2009days of 2\u2032-FL or 28\u2009days of maltodextrin placebo, followed by washout and crossover. Patient-reported outcome measures, feces, urine, and serum samples were collected before and after each intervention, and after a final washout period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Although no clear treatment effect was observed on conventional clinical indices, 2\u2032-FL exposure was associated with improved patient-reported disease control. 2\u2032-FL significantly modulated the gut microbiota, markedly increasing Bifidobacterium abundance (effect size 4.4%, 95% CI 2.33%-6.47%, P\u2009=\u20096.5\u2009\u00d7\u200910\u22125). Fecal metabolite profiles showed changes consistent with altered microbial carbohydrate metabolism. Exploratory analyses suggested that age and baseline microbiota may influence clinical and biological responsiveness to 2\u2032-FL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>2\u2032-FL exposure was associated with improvement in patient-reported disease control, gut microbiota modulation, and cross-compartmental host\u2013microbial metabolic profile modifications; Clinicaltrials.gov number, NCT06050811.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjag120","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:54:55Z","timestamp":1784807695000},"source":"Crossref","is-referenced-by-count":2,"title":["2\u2032-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial"],"prefix":"10.1093","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9335-0808","authenticated-orcid":false,"given":"James M","family":"Kennedy","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Royal Berkshire NHS Foundation Trust , Reading, RG1 5AN,","place":["United Kingdom"]},{"name":"Food Microbial Sciences Unit , The University of Reading , Reading, RG6 6LA,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminda N","family":"De Silva","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Royal Berkshire NHS Foundation Trust , Reading, RG1 5AN,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Sanz","family":"Morales","sequence":"additional","affiliation":[{"name":"Food Microbial Sciences Unit , The University of Reading , Reading, RG6 6LA,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G","family":"Poveda Turrado","sequence":"additional","affiliation":[{"name":"Food Microbial Sciences Unit , The University of Reading , Reading, RG6 6LA,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma E","family":"Walton","sequence":"additional","affiliation":[{"name":"Food Microbial Sciences Unit , The University of Reading , Reading, RG6 6LA,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn R","family":"Gibson","sequence":"additional","affiliation":[{"name":"Food Microbial Sciences Unit , The University of Reading , Reading, RG6 6LA,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"2026082409221004200_jjag120-B1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41579-025-01163-0","article-title":"Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities","volume":"23","author":"Iliev","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"2026082409221004200_jjag120-B2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/gutjnl-2025-335626","article-title":"Gut microbiome in IBD: past, present and the future","volume":"75","author":"Zhang","year":"2026","journal-title":"Gut."},{"key":"2026082409221004200_jjag120-B3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026082409221004200_jjag120-B4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.tim.2023.11.007","article-title":"A review on the use of prebiotics in ulcerative colitis","volume":"32","author":"Kennedy","year":"2024","journal-title":"Trends Microbiol"},{"key":"2026082409221004200_jjag120-B5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/flgastro-2023-102417","article-title":"Role of diet in prevention versus treatment of Crohn\u2019s disease and ulcerative colitis","volume":"15","author":"Halmos","year":"2024","journal-title":"Frontline Gastroenterol"},{"key":"2026082409221004200_jjag120-B6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/jhn.13297","article-title":"What do people with inflammatory bowel disease want to know about diet? The dietary information needs of people with inflammatory bowel disease and perceptions of healthcare providers","volume":"37","author":"Miglioretto","year":"2024","journal-title":"J Hum Nutr Diet"},{"key":"2026082409221004200_jjag120-B7","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1017\/gmb.2022.8","article-title":"Determining the metabolic fate of human milk oligosaccharides: it may just be more complex than you think?","volume":"3","author":"Jackson","year":"2022","journal-title":"Gut Microbiome"},{"key":"2026082409221004200_jjag120-B8","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.1021\/jf0615810","article-title":"A strategy for annotating the human milk glycome","volume":"54","author":"Ninonuevo","year":"2006","journal-title":"J Agric Food Chem"},{"key":"2026082409221004200_jjag120-B9","doi-asserted-by":"publisher","first-page":"116328","DOI":"10.1016\/j.foodres.2025.116328","article-title":"Comprehensive review on human milk oligosaccharides: biosynthesis, structure, intestinal health benefits, immune regulation, neuromodulation mechanisms, and applications","volume":"209","author":"Yu","year":"2025","journal-title":"Food Res Int"},{"key":"2026082409221004200_jjag120-B10","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxae034","article-title":"Comparison of prebiotic candidates in ulcerative colitis using an in vitro fermentation model","volume":"135","author":"Kennedy","year":"2024","journal-title":"J Appl Microbiol"},{"key":"2026082409221004200_jjag120-B11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants","volume":"333","author":"World Medical Association","year":"2025","journal-title":"JAMA"},{"key":"2026082409221004200_jjag120-B12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo- oligosaccharides in active Crohn\u2019s disease","volume":"60","author":"Benjamin","year":"2011","journal-title":"Gut"},{"key":"2026082409221004200_jjag120-B13","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2026082409221004200_jjag120-B14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2026082409221004200_jjag120-B15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"2026082409221004200_jjag120-B16","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/gutjnl-2013-305600","article-title":"Development and validation of a rapid, generic measure of disease control from the patient\u2019s perspective: the IBD-Control questionnaire","volume":"63","author":"Bodger","year":"2014","journal-title":"Gut"},{"key":"2026082409221004200_jjag120-B17","year":"2024"},{"key":"2026082409221004200_jjag120-B18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"Br Med J"},{"key":"2026082409221004200_jjag120-B19","doi-asserted-by":"publisher","DOI":"10.1093\/femsec\/fiw233","article-title":"In vitro fermentation of B-GOS: impact on faecal bacterial populations and metabolic activity in autistic and non-autistic children","volume":"93","author":"Grimaldi","year":"2017","journal-title":"FEMS Microbiol Ecol"},{"key":"2026082409221004200_jjag120-B20","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1038\/s41596-020-0343-3","article-title":"Identifying unknown metabolites using NMR-based metabolic profiling techniques","volume":"15","author":"Garcia-Perez","year":"2020","journal-title":"Nat Protoc"},{"key":"2026082409221004200_jjag120-B21","year":"2025"},{"key":"2026082409221004200_jjag120-B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00925","article-title":"Bifidobacteria and their role as members of the human gut microbiota","volume":"7","author":"O\u2019Callaghan","year":"2016","journal-title":"Front Microbiol"},{"key":"2026082409221004200_jjag120-B23","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.csbj.2021.03.006","article-title":"The genus Bifidobacterium: from genomics to functionality of an important component of the mammalian gut microbiota","volume":"19","author":"Alessandri","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"2026082409221004200_jjag120-B24","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1016\/j.cell.2021.05.030","article-title":"Bifidobacteria-mediated immune system imprinting early in life","volume":"184","author":"Henrick","year":"2021","journal-title":"Cell"},{"key":"2026082409221004200_jjag120-B25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/gut.2006.100164","article-title":"Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study","volume":"56","author":"Penders","year":"2007","journal-title":"Gut"},{"key":"2026082409221004200_jjag120-B26","doi-asserted-by":"publisher","first-page":"101072","DOI":"10.1016\/j.lanmic.2024.101072","article-title":"Investigation of associations between the neonatal gut microbiota and severe viral lower respiratory tract infections in the first 2 years of life: a birth cohort study with metagenomics","volume":"6","author":"Garcia-Mauri\u00f1o","year":"2025","journal-title":"Lancet Microbe"},{"key":"2026082409221004200_jjag120-B27","doi-asserted-by":"publisher","first-page":"fuad039","DOI":"10.1093\/femsre\/fuad039","article-title":"Faecalibacterium: a bacterial genus with promising human health applications","volume":"47","author":"Mart\u00edn","year":"2023","journal-title":"FEMS Microbiol Rev"},{"key":"2026082409221004200_jjag120-B28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tim.2023.11.015","article-title":"Human milk oligosaccharides and Bifidobacterium species","volume":"32","author":"Bakshani","year":"2024","journal-title":"Trends Microbiol"},{"key":"2026082409221004200_jjag120-B29","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"2026082409221004200_jjag120-B30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.clnu.2022.10.024","article-title":"Butyrate\u2019s role in human health and the current progress towards its clinical application to treat gastrointestinal disease","volume":"42","author":"Hodgkinson","year":"2023","journal-title":"Clin Nutr"},{"key":"2026082409221004200_jjag120-B31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12944-024-02203-z","article-title":"Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial","volume":"23","author":"Firoozi","year":"2024","journal-title":"Lipids Health Dis"},{"key":"2026082409221004200_jjag120-B32","doi-asserted-by":"publisher","first-page":"e0161211","DOI":"10.1371\/journal.pone.0161211","article-title":"Mothers secretor status affects development of children\u2019s microbiota composition and function: a pilot study","volume":"11","author":"Smith-Brown","year":"2016","journal-title":"PLoS One"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/8\/jjag120\/70770445\/jjag120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/8\/jjag120\/70770445\/jjag120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:22:24Z","timestamp":1787577744000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjag120\/8769469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjag120","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]},"article-number":"jjag120"}}